Remove Branding Remove Containment Remove RNA
article thumbnail

Vevye: A New Cyclosporine Solution for Dry Eye Disease

XTalks

The solution of Vevye does not contain water, anti-microbial preservatives, oils or surfactants. The exact cost of Vevye has not been publicly disclosed; however, it is estimated that the price of Vevye may be in the range of similar cyclosporine ophthalmic emulsions, such as brand-name Restasis that carries a list price of $645.63

article thumbnail

GSK’s Injectable HIV Treatment Cabenuva Garners FDA Approval

XTalks

The injectable treatment is called Cabenuva and contains two drugs in its injectable formulation — cabotegravir, an integrase inhibitor, and rilpivirine, a second-generation non-nucleoside reverse transcriptase inhibitor. The long-acting injection can help relieve HIV patients from having to take a daily cocktail of pills. Opening up Options.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CureVac : CureVac and Bayer Join Forces on COVID-19 Vaccine Candidate CVnCoV

The Pharma Data

Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. Bayer Forward-Looking Statements This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. billion euros.

article thumbnail

Quality by design with a focus on biosimilars

Pharmaceutical Technology

To demonstrate bioequivalence for a generic small molecule drug, a company must carry out a Phase I clinical trial in healthy individuals to ensure that the area under the curve and maximum plasma concentration for their drug is equivalent to that of the brand name drug. For biosimilars, however, this process is slightly more complex.

article thumbnail

Novartis Leqvio®* (inclisiran) analyses show effective and sustained LDL-C reduction.

The Pharma Data

As the first and only small interfering RNA to provide effective and sustained LDL-C reduction, Leqvio helps manage a critical cardiovascular risk factor for ASCVD. Leqvio is the first and only approved small interfering RNA (siRNA) LDL-C-lowering treatment in Europe 6,7. Product and brand name are currently under FDA review.

RNA 52
article thumbnail

Which Arthritis Painkiller Works the Fastest?

The Pharma Data

Because right now, I’m going to share something BRAND-NEW, backed by mountains of scientific research which will help to treat your pain. For example, studies done on Red Light show it: Because right now, I’m going to share something BRAND-NEW, backed by mountains of scientific research which will help to treat your pain.

article thumbnail

COVID-19 Pandemic Coverage

XTalks

“Vaccine Nationalism” Could Prove the Undoing of COVID-19 Containment. The company’s candidate vaccine, mRNA-1273, is a synthetic messenger RNA that encodes the stabilized SARS-CoV-2 spike protein. Continuing trends suggest the worst may be over provided the outbreak is contained over the next few months. Drugs and Vaccines.